DB
PRVA icon

Dmitry Balyasny’s Privia Health PRVA Stock Holding History

Dmitry Balyasny’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Buy
+8,311
New +$193K ﹤0.01% 2806
2025
Q3 		– Sell
-79,100
Closed -$1.82M – 3366
2025
Q2 		$1.82M Buy
+79,100
New +$1.83M ﹤0.01% 1787
2024
Q4 		– Sell
-11,889
Closed -$216K – 3164
2024
Q3 		$216K Sell
11,889
-11,767
-50% -$225K ﹤0.01% 2541
2024
Q2 		$411K Sell
23,656
-23,119
-49% -$410K ﹤0.01% 2127
2024
Q1 		$916K Buy
+46,775
New +$988K ﹤0.01% 1827
2022
Q3 		– Sell
-7,105
Closed -$207K – 3182
2022
Q2 		$207K Sell
7,105
-180,047
-96% -$4.58M ﹤0.01% 2196
2022
Q1 		$5M Buy
+187,152
New +$4.42M 0.02% 947

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dmitry Balyasny's PRVA Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Privia Health (PRVA) in Q2 2026: 8,311 shares worth $214K. The stake represents ﹤0.01% of the portfolio and ranks #2806 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in PRVA as recently as Q2 2025.

Dmitry Balyasny first reported a position in PRVA in Q1 2022 and has held it in 7 quarters since. The position peaked at $5M in Q1 2022. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Dmitry Balyasny held 8,311 shares of Privia Health worth $214K as of Q2 2026.
  • Privia Health was a new Dmitry Balyasny position in Q2 2026.
  • Privia Health made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2806 holding.
  • Dmitry Balyasny first reported a position in Privia Health in Q1 2022 and has held it in 7 quarters since.
  • Dmitry Balyasny's Privia Health position peaked at $5M in Q1 2022.
  • 300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.